Feeling unreal: A depersonalization disorder update of 117 cases

Journal of Clinical Psychiatry

Volumn 64, Issue 9, 2003, Pages 990-997

  Simeon, Daphne ^a   Knutelska, Margaret ^b   Nelson, Dorothy ^b   Guralnik, Orna ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CANNABIS; CENTRAL STIMULANT AGENT; CLOMIPRAMINE; DOXEPIN; FLUOXETINE; LAMOTRIGINE; LEVOTHYROXINE SODIUM; LIOTHYRONINE; LIOTHYRONINE SODIUM; LITHIUM; MEPROBAMATE; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NEUROLEPTIC AGENT; PSYCHEDELIC AGENT; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AFFECT; ARTICLE; BEHAVIOR THERAPY; CLINICAL FEATURE; COGNITIVE THERAPY; COMORBIDITY; DEPERSONALIZATION; DEPRESSION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; EMOTION; FEMALE; HUMAN; HYPNOSIS; LEISURE; MAJOR CLINICAL STUDY; MALE; PANIC; PRIORITY JOURNAL; PSYCHOTHERAPY; RATING SCALE; SOCIAL INTERACTION; STRESS;

EID: 0141828605     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v64n0903     Document Type: Article

References (30)

1. Simeon D, Gross S, Guralnik O, et al. Feeling unreal: 30 cases of DSM-III depersonalization disorder. Am J Psychiatry 1997;154:1107-1113
2. Sierra M, Berrios GE. The Cambridge Depersonalization Scale: a new instrument for the measurement of depersonalization. Psychiatry Res 2000;93:153-164
3. Simeon D, Guralnik O, Hazlett EA, et al. Feeling unreal: a PET study of depersonalization disorder. Am J Psychiatry 2000;157:1782-1788
4. Phillips ML, Medford N, Senior C, et al. Depersonalization disorder: thinking without feeling. Psychiatry Res 2001;108:145-160
5. Simeon D, Guralnik O, Knutelska M, et al. Hypothalamic-pituitary-adrenal axis dysregulation in depersonalization disorder. Neuropsychopharmacology 2001;25:793-795
6. Sierra M, Senior C, Dalton J, et al. Autonomic response in depersonalization disorder. Arch Gen Psychiatry 2002;59:833-838
7. Simeon D, Guralnik O, Schmeidler J, et al. A double-blind comparison of fluoxetine and placebo in the treatment of depersonalization disorder. Presented at the 57th annual meeting of the Society of Biological Psychiatry; May 16-18, 2002; Philadelphia, Pa. Abstract 137
8. Sierra M, Phillips ML, Ivin G, et al. A placebo-controlled, cross-over trial of lamotrigine in depersonalization disorder. J Psychopharmacol 2003;17:103-105
9. Steinberg M, Rounsaville B, Cicchetti DV. The Structured Clinical Interview for DSM-III-R Dissociative Disorders: preliminary report on a new diagnostic instrument. Am J Psychiatry 1990;147:76-82
10. Steinberg M. Structured Clinical Interview for DSM-IV Dissociative Disorders, Revised (SCID-D). Washington, DC: American Psychiatric Press; 1994
11. Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis 1986;174:727-735
12. Carlson EB, Putnam FW. An update on the Dissociative Experiences Scale. Dissociation 1993;6:16-27
13. van Ijzendoorn MH, Schuengel C. The measurement of dissociation in normal and clinical populations: meta-analytic validation of the Dissociative Experiences Scale (DES). Clin Psychol Rev 1996;16:365-382
14. Carlson EB, Putnam FW, Ross CA, et al. Factor analysis of the Dissociative Experiences Scale: a multicenter study. In: Braun BG, Carlson EB, eds. Proceedings of the 8th International Conference on Multiple Personality and Dissociative States. Chicago, III: Rush; 1991
15. Ross CA, Joshi S, Currie R. Dissociative experiences in the general population: a factor analysis. Hosp Community Psychiatry 1991;42:297-301
16. Ross CA, Ellason JW, Anderson G. A factor analysis of the Dissociative Experiences Scale (DES) in dissociative identity disorder. Dissociation 1995;8:229-235
17. Simeon D, Guralnik O, Gross S, et al. The detection and measurement of depersonalization disorder. J Nerv Ment Dis 1998;168:536-542
18. Waller NG, Putnam FW, Carlson EB. Types of dissociation and dissociative types: a taxometric analysis of dissociative experiences. Psychol Methods 1996;1:300-321
19. Spitzer RL, Williams JB, Gibbons M, et al. Structured Clinical Interview for DSM-III-R-Patient Version (SCID-P). New York, NY: Biometric Research, New York State Psychiatric Institute; 1989
20. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Version (SCID-IP, Version 2.0). New York, NY: Biometric Research, New York State Psychiatric Institute; 1995
21. Spitzer RL, Williams JBW, Gibbons M, et al. Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). New York, NY: Biometric Research, New York State Psychiatric Institute; 1989
22. Pfohl B, Blum N, Zimmerman M. Structured Interview for DSM-IV Personality Disorders SIDP-IV. Iowa City, Iowa: Department of Psychiatry, University of Iowa; 1995
23. Sierra M, Berrios GE. The phenomenological stability of depersonalization: comparing the old with the new. J Nerv Ment Dis 2001;189:629-636
24. Simeon D, Guralnik O, Schmeidler J, et al. The role of childhood interpersonal trauma in depersonalization disorder. Am J Psychiatry 2001;158:1027-1033
25. Szymanski HV. Prolonged depersonalization after marijuana use. Am J Psychiatry 1981;138:231-233
26. Keshaven MS, Lishman WA. Prolonged depersonalization following cannabis abuse. Br J Addict 1986;81:140-142
27. Comfort A. Out-of-body experiences and migraine [letter]. Am J Psychiatry 1982;139:1379-1380
28. Waller NG, Ross CA. The prevalence and biometric structure of pathological dissociation in the general population: taxometric and behavior genetic findings. J Abnorm Psychol 1997;106:499-510
29. Jang KL, Paris J, Zweig-Frank H, et al. Twin study of dissociative experience. J Nerv Ment Dis 1998;186:345-351
30. Hunter E. Cognitive behavioural therapy for depersonalization disorder: preliminary findings from a small scale clinical trial. Presented at the 17th annual meeting of the International Society for the Study of Dissociation; Nov 12-14, 2000; San Antonio, Tex